Dexcom (DXCM) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.79% |
| Dec 31, 2025 | 13.64% |
| Sep 30, 2025 | -15.31% |
| Jun 30, 2025 | -2.85% |
| Mar 31, 2025 | -9.13% |
| Dec 31, 2024 | 21.36% |
| Sep 30, 2024 | -9.44% |
| Jun 30, 2024 | -5.78% |
| Mar 31, 2024 | 7.91% |
| Dec 31, 2023 | 13.01% |
| Sep 30, 2023 | -11.87% |
| Jun 30, 2023 | -31.82% |
| Mar 31, 2023 | -8.19% |
| Dec 31, 2022 | -3.20% |
| Sep 30, 2022 | -9.15% |
| Jun 30, 2022 | -8.17% |
| Mar 31, 2022 | -31.64% |
| Dec 31, 2021 | -53.45% |
| Sep 30, 2021 | -62.54% |
| Jun 30, 2021 | -58.57% |
| Mar 31, 2021 | -47.11% |
| Dec 31, 2020 | -47.98% |
| Sep 30, 2020 | -42.83% |
| Jun 30, 2020 | -40.30% |
| Mar 31, 2020 | -47.48% |
| Dec 31, 2019 | -39.79% |
| Sep 30, 2019 | -39.49% |
| Jun 30, 2019 | -63.18% |
| Mar 31, 2019 | -86.21% |
| Dec 31, 2018 | -83.53% |
| Sep 30, 2018 | -50.49% |
| Jun 30, 2018 | -45.27% |
| Mar 31, 2018 | -56.14% |
| Dec 31, 2017 | -62.31% |
| Sep 30, 2017 | -53.24% |
| Jun 30, 2017 | -52.00% |
| Mar 31, 2017 | -20.88% |
| Dec 31, 2016 | -8.57% |
| Sep 30, 2016 | -5.52% |
| Jun 30, 2016 | -1.94% |
| Mar 31, 2016 | -94.71% |
| Dec 31, 2015 | -19.58% |
| Sep 30, 2015 | -82.94% |
| Jun 30, 2015 | -74.13% |